Integrated pharmacokinetic-pharmacodynamic modeling and allometric scaling for optimizing the dosage regimen of the monoclonal ior EGF/r3 antibody

Author： Duconge J. Castillo R. Crombet T. Alvarez D. Matheu J. Vecino G. Alonso K. Beausoleil I. Valenzuela C. Becquer M.A. Fernandez-Sanchez E.

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.21, Iss.2, 2004-02, pp. : 261-270

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis

Fundamental & Clinical Pharmacology, Vol. 30, Iss. 5, 2016-10 ,pp. : 459-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

An integrated pharmacokinetic–pharmacodynamic model for an Aurora kinase inhibitor

By Kamei Hiroko Jackson Robert Zheleva Daniella Davidson Fordyce

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 4, 2010-08 ,pp. : 407-434

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modeling of GLP-1 in Healthy Rats

By Cao Yanguang Gao Wei Jusko William

Pharmaceutical Research, Vol. 29, Iss. 4, 2012-04 ,pp. : 1078-1086

Springer Publishing Company

Access to resources Recommend Favorite

Mixture Modeling for the Detection of Subpopulations in a Pharmacokinetic/Pharmacodynamic analysis

By Lemenuel-diot Annabelle Laveille Christian Frey Nicolas Jochemsen Roeline Mallet Alain

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 2, 2007-04 ,pp. : 157-181

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modeling of Anesthetics in Children: Therapeutic Implications

By Mazoit Jean-Xavier

Pediatric Drugs, Vol. 8, Iss. 3, 2006-01 ,pp. : 139-150

Adis International

Access to resources Recommend Favorite